Multiple Myeloma Real-World Data
Multiple myeloma is most common in older people, 65+ with on average 1 in 3 people diagnosed resulting in death.
Qdata® can help lead to better treatments.
Qdata® Multiple Myeloma is an exclusive dataset providing a clear view of how patients are treated over time, including lines of therapy, transplant decisions, and outcomes in real world.
Key Data Elements
Demographics
Molecular Markers
Performance Status
All Lines of Therapy
Transplant Data
CAR-T Cell Therapy
Survival & Outcomes
Disease Subtypes
About Qdata® Multiple Myeloma
Multiple myeloma is a rare but serious blood cancer that begins in the bone marrow. It occurs when healthy plasma cells-white blood cells that produce infection-fighting antibodies-turn cancerous and multiply uncontrollably, crowding out normal, healthy cells.
Multiple myeloma medical research is aided by deeply abstracted, longitudinal patient records that captures the complexity of multiple myeloma from diagnosis ad cytogenetic risk through successive lines of therapy and documented outcomes. Structured with clinical oversight and used in regulatory submissions.
The multiple myeloma dataset reflects the full treatment landscape, from conventional regimens to advanced call therapies. Each line of therapy is documented in sequence, providing a clear view of how patients move through treatment over time.
Evidence in Action
Comprehensive Coverage Across the Full Multiple Myeloma Continuum
With 86% of patients with performance status, 32.7 performance statuses on average per patient and 5.8 years average length of follow-up, the dataset reflects the specialized care setting central to multiple myeloma management.
Comprehensive Coverage of Multiple Myeloma Treatment Modalities
The multiple myeloma dataset reflects the full treatment landscape, from conventional regimens to advanced cell therapies. Each line of therapy is documented in sequence, providing a clear view of how patients move through treatment over time.
Custom Data Curation
Need data tailored to your exact study design requirements?
Our purpose-built, fit-for-purpose datasets are designed to support rigorous research and confident decision-making. These datasets can be tailored
around custom inclusion and exclusion criteria, in addition to including all standard abstracted data elements.
Ready to Explore the Multiple Myeloma Dataset?
Connect with our team to discuss your research objectives and receive a tailored data overview.